Table.
Important outcomes | Subsequent pregnancy | ||||||||
Studies (Participants) | Outcome | Comparison | Type of evidence | Quality | Consistency | Directness | Effect size | GRADE | Comment |
What are the effects of treatments for unruptured tubal ectopic pregnancy on subsequent fertility? | |||||||||
5 (295) | Subsequent pregnancy | Methotrexate (single or multiple dose) versus salpingotomy | 4 | –1 | 0 | 0 | 0 | Moderate | Quality point deducted for early termination of planned recruitment in 1 RCT |
1 (446) | Subsequent pregnancy | Salpingectomy versus salpingotomy | 4 | –1 | 0 | 0 | 0 | Moderate | Quality point deducted for incomplete reporting of results |
2 (127) | Subsequent pregnancy | Salpingotomy by laparoscopy versus salpingotomy by laparotomy | 4 | –1 | 0 | 0 | 0 | Moderate | Quality point deducted for sparse data |
We initially allocate 4 points to evidence from RCTs, and 2 points to evidence from observational studies. To attain the final GRADE score for a given comparison, points are deducted or added from this initial score based on preset criteria relating to the categories of quality, directness, consistency, and effect size. Quality: based on issues affecting methodological rigour (e.g., incomplete reporting of results, quasi-randomisation, sparse data [<200 people in the analysis]). Consistency: based on similarity of results across studies. Directness: based on generalisability of population or outcomes. Effect size: based on magnitude of effect as measured by statistics such as relative risk, odds ratio, or hazard ratio.